Search in:

Advanced search

Expert Opinion on Drug Safety Volume 9, 2010 - Issue 1

Submit an article Journal homepage

541

Views

CrossRef citations to date

Altmetric

Reviews

Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex

Charles Craddock Queen Elizabeth Hospital, Birmingham, UK +44 (0)121 472 1311;+44 (0)121 697 8401;[email protected]; Salford Royal NHS Foundation Trust, Manchester, UK

James Anson Royal Liverpool Hospital, Liverpool, UK; Salford Royal NHS Foundation Trust, Manchester, UK

Patrick Chu Royal Liverpool Hospital, Liverpool, UK; Salford Royal NHS Foundation Trust, Manchester, UK

Andrew Dodgson Central Manchester University Hospitals, Manchester, UK; Salford Royal NHS Foundation Trust, Manchester, UK

Nick Duncan Queen Elizabeth Hospital, Birmingham, UK +44 (0)121 472 1311;+44 (0)121 697 8401;[email protected]; Salford Royal NHS Foundation Trust, Manchester, UK

Cesar Gomez James Paget Hospital, Great Yarmouth, UK; Salford Royal NHS Foundation Trust, Manchester, UK

Jayesh Mehta Northwestern University, Chicago, USA; Salford Royal NHS Foundation Trust, Manchester, UK

Shalal Sadullah James Paget Hospital, Great Yarmouth, UK; Salford Royal NHS Foundation Trust, Manchester, UK

Chinari Subudhi Queen Elizabeth Hospital, Birmingham, UK +44 (0)121 472 1311;+44 (0)121 697 8401;[email protected]; Salford Royal NHS Foundation Trust, Manchester, UK

John-Liu Yin Central Manchester University Hospitals, Manchester, UK; Salford Royal NHS Foundation Trust, Manchester, UK

show all

Pages 139-147 | Published online: 01 Dec 2009

Cite this article
https://doi.org/10.1517/14740330903418430

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Mehta J, Kelsey S, Chu P, Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies. Bone Marrow Transplant 1997;20:39-43
PubMed Web of Science ®Google Scholar
Walsh TJ, Hiemenz JW, Seibel NL, Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998;26:1383-96
PubMed Web of Science ®Google Scholar
Fleming RV, Kantarjian HM, Husni R, Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia. Leuk Lymphoma 2001;40:511-20
PubMed Web of Science ®Google Scholar
Herbrecht R, Auvrignon A, Andrès E, Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients. Eur J Clin Microbiol Infect Dis 2001;20:77-82
PubMed Web of Science ®Google Scholar
Wingard JR, White MH, Anaissie E, A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis 2000;31:1155-63
PubMed Web of Science ®Google Scholar
Antoniadou A, Dupont B. Lipid formulations of amphotericin B: where are we today? J Mycolog Med 2005;15:230-38
Web of Science ®Google Scholar
Saliba F, Dubont B. Renal impairment and amphotericin B formulations in patients with invasive fungal infections. Med Mycol 2008;46:97-112
PubMed Web of Science ®Google Scholar
Wiley JM, Seibel NL, Walsh TJ. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr Infect Dis J 2005;24:167-74
PubMed Web of Science ®Google Scholar
Furebring M, Oberg G, Sjolin J. Side effects of amphotericin B lipid complex in the Scandinavian population. Bone Marrow Transplant 2000;25:341-3
PubMed Web of Science ®Google Scholar
Warnock DW. Trends in the epidemiology of invasive fungal infections. Jpn J Med Mycol 2007;48:1-12
Google Scholar
Singh N. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis 2001;33:1692-6
PubMed Web of Science ®Google Scholar
Eccles M, Freemantle N, Mason J. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. BMJ 1998;316:1232-1235
PubMed Web of Science ®Google Scholar
Bowden R, Ckandrasekar P, White M, A double-blind randomized controlled trial of amphotericin B colloidal dispersion versus amphotericin B for the treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2002;35:359-66
PubMed Web of Science ®Google Scholar
White M, Bowden R, Sandler E, Randomised double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia. Clin Infect Dis 1998;27:296-302
PubMed Web of Science ®Google Scholar
Walsh TJ, Finberg RW, Arndt C, Liposomal amphotericin B for empirical therapy in patients with persistant fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999;340:764-71
PubMed Web of Science ®Google Scholar
Rogers DP, Pearson MM, Cleary JD, Differential expression of genes encoding immunomodulatory proteins in response to amphotericin B in human mononuclear cells identified by cDNA microarray analysis. J Antimicrob Chemother 2002;50:811-7
PubMed Web of Science ®Google Scholar
Cleary JD, Schwartz M, Rogers DP, Effects of amphotericin B and caspofungin on histamine expression. Pharmacotherapy 2003;23:966-73
PubMed Web of Science ®Google Scholar
Conti B, Tabarean I, Andrei C, Cytokines and fever. Front Biosci 2004;1:1433-49
Web of Science ®Google Scholar
Goodwin SD, Cleary JD, Walawander CA, Pretreatment regimens for adverse events related to infusion of Amphotericin B. Clin Infect Dis 1995;20:775-61
Google Scholar
O'Connor N, Borley A. Prospective audit of the effectiveness of hydrocortisone premedication on drug delivery reactions following amphotericin B lipid complex. Curr Med Res Opin 2009;25:749-54
PubMed Web of Science ®Google Scholar
Paterson DL, David K, Mrsic M, Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry. J Antimicrob Chemother 2008;62:1392-400
PubMed Web of Science ®Google Scholar
Kuti JL, Kotapati S, Williams P, Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections. Pharmacoeconomics 2004;22:301-10
PubMed Web of Science ®Google Scholar
Aguado JM, Lumbreras C, González-Vidal D. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain. Clin Microbiol Infect 2004;10:785-90
PubMed Web of Science ®Google Scholar
Clevenbergh P, Jacobs F, Kentos A. Compassionate use of amphotericin B lipid complex (Abelcet) in life-threatening fungal infections: report of 30 courses. Clin Microbiol Infect 1998;4:192-8
PubMedGoogle Scholar
Sharkey P, Graybill J, Johnson E, Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996;22:315-21
PubMed Web of Science ®Google Scholar
Mattiuzzi GN, Kantarjian H, Faderl S. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer 2004;1:581-9
Web of Science ®Google Scholar
Martino R, Subirá M, Sureda A, Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies. J Antimicrob Chemother 1999;44:569-72
PubMed Web of Science ®Google Scholar
Martino R, Cortés M, Subirá M, Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies. Leuk Lymphoma 2005;46:1429-435
PubMed Web of Science ®Google Scholar
Subirà M, Martino R, Gómez L, Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial. Eur J Haematol 2004;72:342-7
PubMed Web of Science ®Google Scholar
Linden P, Williams P, Chan KM. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Clin Transplantation 2000;14:329-39
PubMed Web of Science ®Google Scholar
Deray G. Amphotericin B nephrotoxicity. J Antimicrob Chemother 2002;49(Suppl 1):37-41
PubMed Web of Science ®Google Scholar
Mayer J, Doubek M, Doubek J, Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study. J Infect Dis 2002;186:379-88
PubMed Web of Science ®Google Scholar
Holler B, Omar SA, Farid MD, Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants. Pediatrics 2004;113:e608-16
PubMed Web of Science ®Google Scholar
Echevarria J, Seas C, Cruz M, Oral rehydration solution to prevent nephrotoxicity of amphotericin B. Am J Trop Med Hyg 2006;75:1108-12
PubMed Web of Science ®Google Scholar
Miller CB, Waller EK, Klingemann HG, Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients. Bone Marrow Transplant 2004;33:543-8
PubMed Web of Science ®Google Scholar
Wong-Beringer A, Jacobs RA, Guglielmo J. Lipid formulations of amphotericin B: Clinical efficacy and toxicities. Clin Infect Dis 1998;27:603-18
PubMed Web of Science ®Google Scholar
Alexander BD, Wingard JR. Study of renal safety in amphotericin B lipid complex-treated patients. Clin Infect Dis 2005;40:S414-21
PubMed Web of Science ®Google Scholar
Larkin JA, Montero JA. Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med 2003;20:201-6
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date